William Blair Forecasts FibroGen’s Q1 Earnings (NASDAQ:FGEN)
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities researchers at William Blair issued their Q1 2026 earnings estimates for FibroGen in a research report issued on Tuesday, April 1st. William Blair analyst A. Hsieh expects that the biopharmaceutical company will post earnings of ($0.21) per share for the quarter. William Blair has a “Market Perform” […]
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities researchers at William Blair issued their Q1 2026 earnings estimates for FibroGen in a research report issued on Tuesday, April 1st. William Blair analyst A. Hsieh expects that the biopharmaceutical company will post earnings of ($0.21) per share for the quarter. William Blair has a “Market Perform” […]
